(1)
Thuy, N. T. T.; Duyen, T. T. M.; Chi, N. V. L.; Dung, P. T. Economic Value of Subcutaneous Versus Intravenous Trastuzumab Administration in the Treatment of HER2-Positive Breast Cancer: A Systematic Review. HIUJS 2024, 7, 61-72.